Chesney Castleberry, M.D.

Profile picture
Assistant Professor of Pediatrics, Cardiology

phone: (314) 454-6095

Clinical Interests

Primary clinical interest is in the field of heart failure, cardiomyopathy, mechanical circulatory support, and heart transplantation. Also have clinical interest in aquired immune deficiencies especially as they relate to sequale of cardiac operations and transplantation.


  • BA, Texas A&M University2001
  • MD, University of Texas Medical School2005


  • Resident, Children’s Memorial Hospital2005 - 2008
  • Fellow, Children’s Hospital of Wisconsin2008 - 2011
  • Advanced Fellow, Lucile Packard Children’s Hospital2011 - 2012
  • Masters of Science in Clinical Investigation, Washington University in St. Louis School of Medicine2017

Licensure and Board Certification

  • WI, Wisconsin License 2008
  • American Board of Pediatrics 2009
  • CA, California License 2012
  • Advanced Cardiovascular Life Support 2012
  • American Board of Pediatric Cardiology 2013
  • Heartware 2013
  • OH, Ohio License 2013
  • Thoratec Centrimag/Pedimag 2013
  • KY, Kentucky License 2013
  • Syncardia C2 2014
  • Syncardia Freedom Driver 2014
  • Thoratec Heartmate II 2014
  • Pediatric Advanced Life Support 2015
  • MO, Missouri License 2015


  • Medical College of Wisconsin Fellow Research Award2010
  • International Society of Heart and Lung Transplant Registry, Early Career Award2014
  • Mentor- Summer Undergraduate Research Fellowship, Capstone Poster Presentation- 1st Place Award2015

Recent Publications view all (19)

Publication Co-Authors

  1. Early stroke post-heart transplant is associated with decreased survival in children. J Heart Lung Transplant. 2018;37(6):733-739. PMID:29395751 
  2. No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. JACC Heart Fail. 2018;6(3):222-230. PMCID:PMC5834393  PMID:29428438 
  3. End-stage renal disease after pediatric heart transplantation: A 25-year national cohort study. J Heart Lung Transplant. 2017. PMCID:PMC5880747  PMID:29055603 
  4. Pediatric Cardiomyopathies. Circ Res. 2017;121(7):855-873. PMID:28912187 
  5. Clinical practice patterns are relatively uniform between pediatric heart transplant centers: A survey-based assessment. Pediatr Transplant. 2017;21(5). PMID:28670871 
  6. A Novel Surgical Approach to Mechanical Circulatory Support in Univentricular Infants. Ann Thorac Surg. 2017. PMID:28720202 
  7. Risk stratification to determine the impact of induction therapy on survival, rejection and adverse events after pediatric heart transplant: A multi-institutional study. J Heart Lung Transplant. 2017. PMID:28619384 
  8. Pediatric Heart Transplantation Long-Term Survival in Different Age and Diagnostic Groups: Analysis of a National Database. World J Pediatr Congenit Heart Surg. 2017;8(3):337-345. PMID:29957123 
  9. Interaction of older donor age and survival after weight-matched pediatric heart transplantation. J Heart Lung Transplant. 2017;36(5):554-558. PMID:28073609 
  10. Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation. J Heart Lung Transplant. 2017. PMID:28465118 
  11. Outcomes and Trends of Ventricular Assist Device Selection in Children with End-Stage Heart Failure. ASAIO J. 2017;63(4):464-469. PMID:28009713 
  12. Transplant Survival After Berlin Heart EXCOR Support. ASAIO J. 2017;63(1):80-85. PMID:27660899 
  13. Allosensitization does not alter post-transplant outcomes in pediatric patients bridged to transplant with a ventricular assist device. Pediatr Transplant. 2016;20(4):559-64. PMID:27102953 
  14. Early initiation of mTOR inhibitors in children with heart transplantation: A propensity-based registry analysis. J Heart Lung Transplant. 2016;35(2):253-5. PMID:26612055 
  15. Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient. Pediatr Transplant. 2015;19(7):E165-9. doi:10.1111/petr.12584  PMID:26374667 
  16. Pediatric heart transplant waiting list mortality in the era of ventricular assist devices. J Heart Lung Transplant. 2015;34(1):82-8. doi:10.1016/j.healun.2014.09.018  PMID:25447574 
  17. Hypoalbuminemia and poor growth predict worse outcomes in pediatric heart transplant recipients. Pediatr Transplant. 2014;18(3):280-7. doi:10.1111/petr.12239  PMID:24646199 
  18. Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid. J Am Coll Cardiol. 2014;63(12):1224-6. doi:10.1016/j.jacc.2013.09.029  PMID:24140666 
  19. Stenting of the right ventricular outflow tract in the high-risk infant with cyanotic teratology of Fallot. Pediatr Cardiol. 2014;35(3):423-30. doi:10.1007/s00246-013-0796-z  PMID:24096718 
Last updated: 07/25/2018
© 2019 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130